Basilea Pharmaceutica AG (BPMUF)
76.25
-1.15
(-1.49%)
USD |
OTCM |
Oct 02, 16:00
Basilea Pharmaceutica Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 7.822 |
| AC Immune SA | 5.694 |
| CRISPR Therapeutics AG | 3.068 |
| Idorsia Ltd. | -- |
Price to Book Value Related Metrics
| PE Ratio | 15.50 |
| PS Ratio | 3.348 |
| Price to Free Cash Flow | 14.63 |
| Price | 76.25 |
| Earnings Yield | 6.45% |
| Market Cap | 945.73M |
| Operating PE Ratio | 14.01 |
| Normalized PE Ratio | 15.50 |